Our Products

We have a portfolio of rapid point-of-care tests for early disease detection and assessment of response to therapeutics.

Today, our portfolio addresses:

Maternal health

  • Preeclampsia
  • Gestational diabetes

Diabetes

  • Type 1
  • Type 2

Autoimmune

  • Rheumatoid arthritis
  • COVID antibodies

Lumella​®

The Lumella® test estimates the concentration of Glycosylated Fibronectin, a new pregnancy specific biomarker to accurately assess the risk of preeclampsia.
 

Learn More

Insudex​®

The first and only point-of-care tests for early detection of type-1 diabetes and LADA (Latent Autoimmune Diabetes in Adults).

Learn More

Glucema​®

Introducing Glucema®
Non-invasive Diabetes Testing and Monitoring
The first and only point-of-care saliva test for diabetes monitoring.

Learn More

RAprime

Rapid point-of-care tests for rheumatoid arthritis screening, diagnosis, and intervention.
 

Learn More

Scroll to Top